#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital aplastic anaemia Hypocalcaemia Rectal cancer Keratosis follicular Haemolytic uraemic syndrome Meningitis meningococcal Soft tissue sarcoma Autoimmune demyelinating disease Atypical haemolytic uraemic syndrome Nephrotic syndrome Multifocal motor neuropathy Laryngeal squamous cell carcinoma Small for dates baby Cholangiosarcoma Primitive neuroectodermal tumour More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Life with Disease Mastocytosis Idiopathic pulmonary fibrosis – Treatment Rhabdomyosarcoma – Basic Information Rosai-Dorfman syndrome Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Kearns-Sayre syndrome – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Tuberous sclerosis complex – Diagnostics Gastrointestinal stromal tumour More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fedratinib Seladelpar Ondansetron Hydrochloride Alectinib Roxithromycin Clofarabine Vixarelimab Avacincaptad Pegol Regn7508 Clemizole Hydrochloride Human Fibrinogen Remifentanil Hydrochloride Dog Epithelium Extract MRNA-1345 Amsacrine Avalglucosidase Alfa Blood And Related Products Isoleucine Artemisia Vulgaris (312) TRV045 More therapies…

    Learn about Your Condition

    Peripheral artery thrombosis Conjunctivitis Delayed graft function Oropharyngeal cancer recurrent Acute myocardial infarction Lymphangioleiomyomatosis T-cell type acute leukaemia Cutaneous lupus erythematosus Vasoplegia syndrome Colon cancer stage II Pericarditis Small intestine carcinoma Extra-osseous Ewing's sarcoma Inclusion body myositis Sinus rhythm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Praxis Springub-Schwarz

Praxis Springub-Schwarz

Kuhlenstraße 2, Westerstede, 26655, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on LY3848575 for Reducing Pain in Patients with Distal Sensory Polyneuropathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Polyneuropathy
    • Neuralgia
    Investigated Drugs:
    • LY3848575
    Germany Poland

  • Study on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Diphenhydramine Hydrochloride
    • Ocrelizumab
    • Methylprednisolone
    Czechia Denmark France Germany Italy The Netherlands +1

  • Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Deudextromethorphan Hydrobromide
    • Quinidine Sulfate
    Bulgaria Denmark Estonia Germany Greece Poland +1

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!